Skip to main content

Table 1 Power (%) of seven methods to detect association of rare variants under seven scenarios for underlying genetic architecture using data simulated for BRCA1 in 2000 cases and 2000 controls

From: The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

  

Threshold for significance

  

P < 0.001

P < 0.01

P < 0.05

Scenario*

Proportion of variants associated

RAML

SKAT-O

T1

T5

WST

VTT

EREC

RAML

SKAT-O

T1

T5

WST

VTT

EREC

RAML

SKAT-O

T1

T5

WST

VTT

EREC

1

0.05

5.0

4.5

3.0

2.5

2.0

3.0

3.0

15.0

11.0

10.0

7.5

8.0

7.0

10.0

30.0

29.0

22.5

18.5

20.5

19.5

26.0

2

0.05

5.0

6.5

1.5

2.0

1.0

1.5

3.0

11.5

11.5

4.5

6.0

5.5

9.0

8.0

28.0

21.5

14.5

10.5

13.5

17.0

16.0

3

0.05

7.5

5.0

2.5

0.5

1.5

1.5

4.0

13.5

11.0

7.0

6.0

7.0

7.0

8.0

25.5

26.0

16.0

19.5

17.0

17.5

22.5

4

0.05

7.0

4.0

2.0

1.0

1.0

1.0

2.5

14.0

12.5

5.0

3.5

5.0

4.5

8.0

26.0

23.5

12.5

12.0

9.5

10.0

21.0

5

0.05

6.5

5.0

2.0

2.0

1.5

2.0

3.5

14.5

9.5

5.0

2.5

3.5

5.5

6.5

27.5

18.0

11.5

8.0

10.0

13.5

14.5

6

0.05

9.0

4.5

1.0

0.5

0.5

1.0

3.5

16.0

11.0

5.0

4.0

3.0

3.0

8.5

26.0

20.5

12.5

10.5

11.0

10.5

18.5

7

0.05

8.5

5.0

1.0

1.5

0.5

1.5

4.0

16.0

8.0

3.0

4.0

3.5

4.0

7.5

24.5

21.5

8.0

8.5

6.5

10.0

16.5

1

0.10

7.5

6.0

6.0

2.0

5.0

4.5

5.5

14.5

16.0

11.0

8.0

10.0

11.0

15.0

30.0

30.0

24.5

21.5

20.0

20.5

25.0

2

0.10

2.5

3.5

1.5

2.0

1.5

0.5

1.5

8.5

8.5

6.0

5.5

7.0

6.5

10.5

26.0

24.0

19.5

17.5

17.5

17.5

20.5

3

0.10

4.5

5.0

3.0

2.5

3.0

1.5

3.5

10.5

8.5

7.0

4.5

5.5

7.5

8.5

22.0

19.5

15.0

11.5

14.0

15.5

18.5

4

0.10

3.5

3.0

2.0

2.0

1.5

1.5

2.5

9.5

10.5

6.0

3.0

4.5

3.5

7.5

22.0

18.5

13.5

13.0

13.0

12.5

17.5

5

0.10

4.0

4.5

3.0

1.0

1.5

3.0

2.5

10.5

9.0

5.5

3.0

5.0

5.5

9.0

23.0

21.0

13.0

11.5

14.0

14.5

22.0

6

0.10

2.5

3.5

1.5

1.0

1.5

1.0

1.5

9.0

9.0

5.0

2.5

5.5

3.5

5.5

21.0

18.0

10.0

9.0

9.0

11.0

16.5

7

0.10

4.0

3.0

1.0

1.0

0.5

2.0

3.5

11.0

10.5

2.5

5.0

3.0

3.0

7.5

25.5

20.0

11.5

11.5

12.0

12.5

17.0

1

0.20

6.5

7.5

7.5

4.0

5.5

4.5

7.5

23.5

27.5

23.5

18.5

24.5

20.5

25.5

40.0

44.5

44.0

40.0

44.5

39.0

43.5

2

0.20

4.0

6.5

4.5

2.0

4.5

4.0

4.5

14.0

12.5

14.0

7.0

10.0

9.5

12.5

23.0

26.5

23.5

16.5

22.5

23.0

24.0

3

0.20

5.0

6.0

5.5

3.5

5.0

5.5

5.0

14.5

17.0

15.0

12.5

16.5

13.0

17.0

27.5

36.5

31.0

28.5

34.0

30.0

35.5

4

0.20

2.5

3.0

1.5

1.5

1.5

1.0

2.0

7.5

10.5

5.0

6.5

5.5

5.0

8.0

18.5

21.5

16.0

14.0

16.5

17.0

18.5

5

0.20

4.5

5.0

1.0

1.0

1.5

1.0

2.5

10.5

9.0

7.0

4.0

4.5

6.0

8.0

24.0

25.5

17.5

13.5

15.0

14.5

20.5

6

0.20

0.5

1.0

0.0

0.0

0.5

0.0

0.5

6.5

6.5

3.5

2.5

2.0

1.5

4.5

17.0

20.0

10.0

12.0

11.0

8.5

18.5

7

0.20

3.0

3.5

0.5

0.5

1.0

0.5

0.5

9.0

9.5

3.0

4.0

2.5

3.5

6.5

23.5

21.5

12.0

9.5

12.0

12.0

17.5

  1. Method with greatest power emboldened.
  2. * See text for description of genetic architecture for each scenario.
  3. RAML Rare admixture maximum likelihood, SKAT-O sequence kernel association test, T1fixed threshold test 1 per cent MAF, T5 fixed threshold test 5 per cent MAF, WST weighted sum test, VTT variable threshold test, EREC estimated regression coefficient test.